Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

9.45B

Market cap9.45B

Price-Earnings ratio

-3.23

Price-Earnings ratio-3.23

Dividend yield

—

Dividend yield—

Average volume

11.12M

Average volume11.12M

High today

$24.34

High today$24.34

Low today

$23.33

Low today$23.33

Open price

$23.81

Open price$23.81

Volume

9.16M

Volume9.16M

52 Week high

$79.96

52 Week high$79.96

52 Week low

$23.15

52 Week low$23.15

MRNA News

Seeking Alpha 3d

Pfizer, Moderna in focus as Trump demands answers on COVID success

Pandemic-era favorites such as Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) will be under scrutiny after President Donald Trump on Monday urged the companies to...

Analyst ratings

63%

of 27 ratings

Buy

22.2%

Hold

63%

Sell

14.8%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.